THE last of the regular publications of the summary of Yellow Card reporting for Covid-19 vaccines produced by the MHRA was published last month, as we reported here. However, thanks to the diligence of Jenny Brown we are still able to access Yellow Card data from MHRA’s ‘new interactive’ format for the many drugs they say have an acceptable safety profile. These perversely include the Covid vaccines.
Just how misleading and negligent is this safety judgement is highlighted by the Perseus Report’s condemnation of the MHRA’s shocking failings, reported yesterday in these pages. It is also cruelly brought home by the the latest of our series of vaccine injury stories. Today’s mother’s tale of her beautiful daughter’s disablement following a Pfizer vaccination brain bleed is a harrowing read. It highlights the new corruption pervading the NHS rooted in MHRA’s single minded promotion of gene therapy vaccines come what may.
This is what we have been warning about on TCW since July 2021 – when we published our first piece on the scale and seriousness of the vaccines’ adverse effects – and in all our regular MHRA Yellow Card reporting since.
Our latest such breakdown summary from the official published data, extracted by Jenny Brown for TCW, follows below.
Despite the drop-off in the number of doses administered in the last five weeks, vaccination injury numbers continue to rise. In this time period 633 people have been impacted, 75 per cent of whom are acknowledged by MHRA to be serious (and which the MHRA also acknowledges may be less than 10 per cent of the true numbers of people impacted). There have been 14 reports ‘with fatal outcome’ in the five weeks.
However we are no wiser as to the more than 390 fatalities who are recorded to be of ‘Unknown Age’, though this is an alarming 15.8 per cent of all fatalities. Is it possible that these are young people and/or children? The MHRA is not telling us and does not seem concerned. A total of 135 fatalities are also of ‘Unknown Sex’, which equals 5.5 per cent of all deaths. How is this information not known? What efforts has the negligent MHRA made to find out?
Meanwhile the spring and summer ‘primary’ and booster campaign, targeted at babies and children too, . – continues apace.
MHRA Yellow Card reporting summary up to March 29, 2023
New interactive format data
Adult & Child – Primary, Third Dose & Boosters (mono/bivalent)
Government data up to September 11 2022 – UK-wide (latest)
· 1st doses received – 53.8million people
· 2nd doses – 50.7m people
· 3rd doses – one or more booster – 40.6m (up to Feb 2023)
Additional all-brand doses given in last 5 weeks – 324 (Pfizer-mono) + 9,453 (Pfizer-bivalent) + 1 (AZ) + 8 (Moderna-mono) + 1,655 (Moderna-bivalent) = 11,441
65.7% (15,098,879 out of 22,970,162) people aged over 50 years old (England only) had an autumn booster since Sept 2022 (UKHSA National Flu & Covid-19 Surveillance Report – week 14)
Yellow Card Adverse Event Reports – 176,495 (Pfizer-mono) + 4,237 (Pfizer-bivalent) + 247,764 (AZ) + 42,863 (Moderna-mono) + 5,165 (Moderna-bivalent) + 66 (Novavax) + 2,372 (Unknown brand) = 478,962 people impacted (increase of 633 in five weeks)
Reports classified as SERIOUS* by MHRA = 74.4 per cent of all reports
124,777 (Pfizer-mono) + 3,242 (Pfizer-bivalent) + 191,793 (AZ) + 30,959 (Moderna-mono) + 3,735 (Moderna-bivalent) + 46 (Novavax) + 1,716 (Unknown) = 356,268
Over 45,936 of the above serious reports are of ‘Unknown Age’ = 9.6 per cent of all reports
Reports classified as Non-SERIOUS by MHRA = 25.1 per cent
50,848 (Pfizer-mono) + 962 (Pfizer-bivalent) + 54,603 (AZ) + 11,815 (Moderna-mono) + 1,389 (Moderna-bivalent) + 20 (Novavax) + 584 (Unknown) = 120,221
Overall 1 in 112 people injected experiences a Yellow Card Adverse Event (assuming one person submits only one report)
1 in 151 reports are classified as SERIOUS*
1 in 194 reports are associated with a fatality, which may be less than 10 per cent of actual figures according to MHRA.
Reactions – 508,972 (Pfizer-mono) + 11,257 (Pfizer-bivalent) + 878,138 (AZ) + 140,628 (Moderna-mono) + 14,060 (Moderna-bivalent) + 215 (Novavax) + 7,340 (Unknown) = 1,560,610
Fatal – 870 (Pfizer-mono) + 33 (Pfizer-bivalent) + 1,368 (AZ) + 89 (Moderna-mono) + 41 (Moderna-bivalent) + 72 (Unknown) = 2,473 = 0.5 per cent of reports (increase of 14 reports with fatal outcome in five weeks)
Over 390 of the above fatalities are of ‘Unknown Age’ = 15.8 per cent of all fatalities, and 135 are of ‘Unknown Sex’ = 5.5 per cent of all fatalities
Reaction types (one report may include more than one reaction type – partial listing)
Blood & Lymphatic Disorders – 17,414 (Pfizer-mono) + 412 (Pfizer-bivalent) + 7,966 (AZ) + 2,676 (Moderna-mono) + 219 (Moderna-bivalent) + <5 (Novavax) + 80 (Unknown brand) = 28,767
Acute Cardiac Disorders – 14,327 (Pfizer-mono) + 668 (Pfizer-bivalent) + 11,924 (AZ) + 3,842 (Moderna-mono) + 539 (Moderna-bivalent) + 14 (Novavax) + 212 (Unknown) = 31,526
Eye Disorders – 8,452 (Pfizer-mono) + 179 (Pfizer-bivalent) + 15,184 (AZ) + 1,769 (Moderna-mono) + 217 (Moderna-bivalent) + <5 (Novavax) + 127 (Unknown) = 25,928
· Of which Blindness – 182 (Pfizer-mono) + <5 (Pfizer-bivalent) + 337 (AZ) + 47 (Moderna-mono) + <5 (Moderna-bivalent) + 6 (Unknown) = 572
Infections & Infestations – 13,528 (Pfizer-mono) + 432 (Pfizer-bivalent) + 21,125 (AZ) + 2,907 (Moderna-mono) + 393 (Moderna-bivalent) + 9 (Novavax) + 302 (Unknown) = 38,696
Gastrointestinal Disorders – 43,737 (Pfizer-mono) + 945 (Pfizer-bivalent) + 81,499 (AZ) + 12,472 (Moderna-mono) + 1,563 (Moderna-bivalent) + 18 (Novavax) + 540 (Unknown) = 140,774
Immune System Disorders – 2,645 (Pfizer-mono) + 50 (Pfizer-bivalent) + 3,512 (AZ) + 709 (Moderna-mono) + 51 (Moderna-bivalent) + 6 (Novavax) + 56 (Unknown) = 7,029
Nervous System Disorders – 84,131 (Pfizer-mono) + 1,722 (Pfizer-bivalent) + 184,499 (AZ) + 22,924 (Moderna-mono) + 2,359 (Moderna-bivalent) + 28 (Novavax) + 1208 (Unknown) = 296,871
· Of which Seizures – 1,340 (Pfizer-mono) + 23 (Pfizer-bivalent) + 2,316 (AZ) + 335 (Moderna-mono) + 35 (Moderna-bivalent) + <5 (Novavax) + 43 (Unknown) = 4,092
· Paralysis – 554 (Pfizer-mono) + 18 (Pfizer-bivalent) + 927 (AZ) + 146 (Moderna-mono) + 13 (Moderna-bivalent) + 16 (Unknown) = 1,674
· Tremor – 2,307 (Pfizer-mono) + 60 (Pfizer-bivalent) + 10,027 (AZ) + 836 (Moderna-mono) + 103 (Moderna-bivalent) + 64 (Unknown) = 13,397
Respiratory Disorders – 22,859 (Pfizer-mono) + 698 (Pfizer-bivalent) + 30,274 (AZ) + 5,019 (Moderna-mono) + 776 (Moderna-bivalent) + 12 (Novavax) + 334 (Unknown) = 59,972
Reproductive/Breast Disorders – 31,825 (Pfizer-mono) + 159 (Pfizer-bivalent) + 21,031 (AZ) + 5,376 (Moderna-mono) + 95 (Moderna-bivalent) + <5 (Novavax) + 289 (Unknown) = 58,775
Psychiatric Disorders – 10,757 (Pfizer-mono) + 231 (Pfizer-bivalent) + 18,789 (AZ) + 2,837 (Moderna-mono) + 255 (Moderna-bivalent) + <5 (Novavax) + 178 (Unknown) = 33,047
CHILDREN & YOUNG PEOPLE SPECIAL REPORT
Last available data set for under-18s in November 2022
· 4,213,500 children (1st doses) – majority Pfizer
· 2,910,500 (2nd doses) – majority Pfizer
· 485,900 boosters
Yellow Card adverse events reported – Below combined 0-19yrs – many categories retracted (^) ‘due to less than 5 reports in line with MHRA duty of confidentiality to patients and reporters’
0-19yr old reports classified as SERIOUS* by MHRA = 71.4 per cent
4,658 (Pfizer-mono) + 36 (Pfizer-bivalent) + 1,457 (AZ) + 517 (Moderna-mono) + 7 (Moderna-bivalent) + 33 (Unknown) = 6,708
0-19yr old reports classified as FATAL by MHRA
>10 (Pfizer-mono) + zero (Pfizer-bivalent) + <5 (AZ) + <5 (Moderna-mono) + <5 (Moderna-bivalent) + <5 (Unknown brand) = greater than 10
20-29yr old reports classified as SERIOUS* by MHRA = 73.2 per cent
19,975 (Pfizer-mono) + 110 (Pfizer-bivalent) + 14,544 (AZ) + 4,973 (Moderna-mono) + 128 (Moderna-bivalent) + < 5 (Novavax) + 91 (Unknown) = 39,821
20-29yr old reports classified as FATAL by MHRA
15 (Pfizer-mono) + <5 (Pfizer-bivalent) + 28 (AZ) + zero (Moderna-mono) + zero (Moderna-bivalent) + zero (Novavax) + zero (Unknown brand) = greater than 43
* MHRA definition of ‘serious’ – patient died, life threatening, hospitalisation, congenital abnormality, persistent or significant disability or capacity, deemed medically significant by MHRA medical dictionary or reporter.
For full reports see here.
